Transgenic overproduction of islet amyloid polypeptide (amylin) is not sufficient for islet amyloid formation

Hormone and Metabolic Research

Volumn 29, Issue 6, 1997, Pages 311-316

  Verchere, C B ^a,b   D'Alessio, D A ^a   Wang, S ^a   Andrikopoulos, S ^a   Kahn, S E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Hyperglycemia; Insulin; Nicotinic Acid; Non Insulin Dependent Diabetes Mellitus; Pancreatic Beta Cell; Transgenic Mice

Indexed keywords

AMYLIN; AMYLOID; INSULIN; NICOTINIC ACID;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; FAT INTAKE; GENE EXPRESSION; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; INSULIN RESISTANCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0030786638     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979042     Document Type: Conference Paper

References (33)

1. Westermark P, Wernstedt C, Wilander E, Sletten K: A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 827-831 (1986).
2. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islets. Proc Natl Acad Sci USA 84: 3881-3885 (1987).
3. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628-8632 (1987).
4. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky Jr GJ, Porte Jr D: Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 39: 634-638 (1990).
5. Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87: 5036-5040 (1990).
6. Clark A, Saad MF, Nezzer T, Uren C, Knowler WC, Bennett PH, Turner RC: Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians. Diabetologia 33: 285-289 (1990).
7. D'Alessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW: Pancreatic expression and secretion of human IAPP in a transgenic mouse. Diabetes 43: 1457-1461 (1994).
8. Hoppener JWM, Verbeek JS, de Koning EJP, Oosterwijk C, van Hulst KL, Visser-Vernooy HJ, Hofhuis FMA, van Gaalen S, Berends MJH, Hackeng WHL, Jansz HS, Morris JF, Clark A, Capel PJA, Lips CJM: Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 36: 1258-1265 (1993).
9. Yagui K, Yamaguchi T, Kanatsuka A, Shimada F, Huang CI, Tokuyama Y, Ohsawa H, Yamamura K, Miyazaki J, Mikata A: Formation of islet amyloid fibrils in beta secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin. Eur J Endocrinol 132: 487-496 (1995).
10. Fox N, Schrementi J, Nishi M, Ohagi S, Chan SJ, Heisserman J, Westermark GT, Leckstrom A, Westermark P, Steiner DF: Human islet amyloid polypeptide transgenic mice as a model of non-insulin dependent diabetes mellitus (NIDDM). FEBS Lett 323: 40-44 (1993).
11. Porte Jr D: β-cells in type II diabetes mellitus. Diabetes 40: 166-180 (1991).
12. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte Jr D: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672 (1993).
13. Verchere CB, D'Alessio DA, Palmiter RD, Kahn SE: Transgenic mice overproducing human islet amyloid polypeptide have increased insulin storage and secretion in vitro. Diabetologia 37: 725-728 (1994).
14. Morgan DR, Lazarow A: Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes 12: 115-126 (1963).
15. Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93: 3492-3496 (1996).
16. Kahn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky Jr GJ, Porte Jr D: Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38: 562-568 (1989).
17. Ar'Rajab A, Ahren B: Effects of yohimbine and nicotinic acid on insulin secretion in islet transplanted streptozotocin-diabetic rats. Diabetes Res Clin Pract 11: 81-87 (1991).
18. O'Brien TD, Butler PC, Kreutter DK, Kane LA, Eberhardt NL: Human islet amyloid polypeptide expression in COS 1 cells. A model of intracellular amyloidogenesis. Am J Pathol 147: 609-616 (1995).
19. Westermark G, Arora MB, Fox N, Carroll R, Chan SJ, Westermark P, Steiner DF: Amyloid formation in response to beta cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide. Mol Med 1: 542-553 (1995).
20. de Koning EJP: Islet amyloid polypeptide and amyloid fibril formation in diabetes. Thesis Universiteit Utrecht (1994), 35-51.
21. Couce M, Kane LA, O'Brien TD, Charlesworth J, Soeller W, McNeish J, Kreutter D, Roche P, Butler PC: Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta cell dysfunction. Diabetes 45: 1094-1101 (1996).
22. Porte Jr D, Kahn SE: Hyperproinsulinemia and amyloid in NIDDM: clues to etiology of islet β-cell dysfunction? Diabetes 38: 1333-1336 (1989).
23. Tsunehara CH, Leonetti DL, Fujimoto WY: Diet of second generation Japanese American men with and without non insulin dependent diabetes. Am J Clin Nutr 52: 731-738 (1990).
24. Lee SK, Opara EC, Surwit RS, Feinglos MN, Akwari OE: Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. Pancreas 11: 206-211 (1995).
25. Zhou YP, Grill V: Long term exposure to fatty acids and ketones inhibits B cell functions in human pancreatic islets of Langerhans. J Clin Endocrinol Metab 80: 1584-1590 (1995).
26. Zhou YP, Grill VE: Long term exposure of rat pancreatic islets to fatty acids inhibits glucose induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93: 870-876 (1994).
27. Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type 2 diabetes mellitus. Nature 368: 756-760 (1994).
28. Howard Jr CF: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 29: 301-306 (1986).
29. Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC: Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 93: 7283-7288 (1996).
30. Beard JC, Halter JB, Best JD, Pfeifer MA, Porte Jr D: Dexamethasone-induced insulin resistance enhances B-cell responsiveness to glucose level in normal men. Am J Physiol 247: E592-E596 (1984).
31. Rizza RA, Mandarino LJ, Gerich JE: Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31: 663-669 (1982).
32. Kahn SE, Horber FF, Prigeon RL, Haymond MW, Porte Jr D: Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans. Diabetes 42: 1082-1085 (1993).
33. de Koning EJP, Morris ER, Hofhuis FMA, Posthuma G, Hoppener JWM, Morris JF, Capel PJA, Clark A, Verbeek JS: Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. Proc Nad Acad Sci USA 91: 8467-8471 (1994).